XML 80 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation - Summary of SARs Outstanding (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
SARs, beginning balance (shares) | shares 4,905
SARs, granted (shares) | shares 597
SARs, exercised (shares) | shares (297)
SARs, forfeited, canceled or expired (shares) | shares (210)
SARs, ending balance (shares) | shares 4,995
SARs, Vested and expected to vest at ending balance (shares) | shares 4,863
SARs, Exercisable at ending balance (shares) | shares 3,669
Weighted Average Grant Date Fair Value  
SARs, weighted average exercise price, beginning balance (in USD per share) | $ / shares $ 211.47
SARs, weighted average exercise price, granted (in USD per share) | $ / shares 238.89
SARs, weighted average exercise price, exercised (in USD per share) | $ / shares 154.25
SARs, weighted average exercise price, forfeited, canceled or expired (in USD per share) | $ / shares 237.09
SARs, weighted average exercise price, ending balance (in USD per share) | $ / shares 217.07
SARs, weighted average exercise price, vested and expected to vest (in USD per share) | $ / shares 216.50
SARs, weighted average exercise price, exercisable (in USD per share) | $ / shares $ 209.57
SARs, weighted average remaining contractual term (in years) 5 years 3 months
SARs, weighted average remaining contractual term, vested and expected to vest (in years) 5 years 2 months 1 day
SARs, weighted average remaining contractual term, exercisable (in years) 4 years 2 months 4 days
SARs, aggregate intrinsic value | $ $ 125
SARs, aggregate intrinsic value, vested and expected to vest | $ 125
SARs, aggregate intrinsic value, exercisable | $ $ 121